Fall in plasma ghrelin concentrations after cisplatin-based chemotherapy in esophageal cancer patients.
about
Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved.Inhibition of cisplatin-induced lipid catabolism and weight loss by ghrelin in male miceClinical review: The human experience with ghrelin administration.Herbal medicines for the treatment of cancer chemotherapy-induced side effects.A New Strategy Using Rikkunshito to Treat Anorexia and Gastrointestinal DysfunctionChanges in plasma ghrelin and serum leptin levels after Cisplatin-based transcatheter arterial infusion chemotherapy for hepatocellular carcinoma.Increased Ghrelin but Low Ghrelin-Reactive Immunoglobulins in a Rat Model of Methotrexate Chemotherapy-Induced Anorexia.Improvement of cisplatin-related renal dysfunction by synthetic ghrelin: a prospective randomised phase II trialCombined Administration of Human Ghrelin and Human Growth Hormone Attenuates Organ Injury and Improves Survival in Aged Septic Rats.Nutrition therapy issues in esophageal cancer.Clinical application of ghrelin in the field of surgery.Ghrelin promotes oral tumor cell proliferation by modifying GLUT1 expression.What is nausea? A historical analysis of changing views.The efficacy of the Kampo medicine rikkunshito for chemotherapy-induced anorexia (RICH trial): study protocol for a randomized controlled trial.Plasma ghrelin levels as a predictor of adverse renal events due to cisplatin-based chemotherapy in patients with esophageal cancer.Pre-therapy mRNA expression of TNF is associated with regimen-related gastrointestinal toxicity in patients with esophageal cancer: a pilot study.Quinolones Modulate Ghrelin Receptor Signaling: Potential for a Novel Small Molecule Scaffold in the Treatment of Cachexia.
P2860
Q30384810-8CC0D000-E4C4-45B9-99DB-FEFAB24E94CEQ30410972-34D672FA-5697-4DB9-A931-E8F1E2F8F245Q34335494-EE11B678-BCAF-4895-A797-91F19C10C5DBQ35066654-BEE62042-5CBF-4330-9D46-E654E5FB42A6Q35612563-170E3383-25AB-4EB6-A657-983FCDCE993BQ36711597-3BB8A2B3-26B5-4C31-A743-EDFEEFAF2878Q37124526-EA63F356-9B25-434C-9291-FE9F400B9F0DQ37174066-7C04C345-6ED5-4C01-B629-EAE4908CA4B7Q37217033-54C470F3-C245-43D1-844B-C5C06A9E343FQ38021425-0ECE7A80-9891-48F5-8209-37BEF00C76A3Q38264663-3F742964-7BD4-46B9-8567-EF1E315246EFQ38832450-2CB91F2C-2425-4BF1-83CE-B386141E13C6Q38906491-3BEEF18F-938D-4FCA-B234-78A83C045048Q42672307-D0900A1C-4AD3-4198-98E6-A9507DDDDFEFQ53186226-090BB2F4-CEB6-4D7E-B3B3-44C5785CFE00Q54169017-FA914351-C955-4E9F-9244-EC9AE146BDA8Q55646811-8AB55410-4ADD-4515-BD77-D3DAAC6670C3
P2860
Fall in plasma ghrelin concentrations after cisplatin-based chemotherapy in esophageal cancer patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fall in plasma ghrelin concent ...... in esophageal cancer patients.
@en
Fall in plasma ghrelin concent ...... in esophageal cancer patients.
@nl
type
label
Fall in plasma ghrelin concent ...... in esophageal cancer patients.
@en
Fall in plasma ghrelin concent ...... in esophageal cancer patients.
@nl
prefLabel
Fall in plasma ghrelin concent ...... in esophageal cancer patients.
@en
Fall in plasma ghrelin concent ...... in esophageal cancer patients.
@nl
P2093
P2860
P1476
Fall in plasma ghrelin concent ...... in esophageal cancer patients.
@en
P2093
Hiroshi Miyata
Kazuyoshi Yamamoto
Kiyokazu Nakajima
Makoto Yamasaki
Shuji Takiguchi
Yoshiyuki Fujiwara
Yuichiro Hiura
Yukinori Kurokawa
P2860
P2888
P304
P356
10.1007/S10147-011-0289-0
P577
2011-07-20T00:00:00Z